I am
an amblyope. I have had amblyopia as long as I can remember. It’s known as
“lazy eye,” but that is too kind of a euphemism. I’ve been through every
treatment you can imagine over the years, and still I possess 20/200 vision in
my right eye. Amblyopia’s effects on my eyes have been deleterious, to say the
least. It affects my work, learning, driving, sports abilities, entertainment,
and my ability to enjoy Colorado’s beautiful natural environment, which so
richly surrounds me.
Many
amblyopes cannot see 3D movies or media without discomfort, if at all. I am an
outlier. For some clinically veiled reason, I can enjoy 3D fully. And do I
ever.
In
promising development, we are seeing some of the innovations used in 3D
technology now being applied to the arena of vision care and treatment. Building
upon their intense expertise in optics and 3D glasses technologies, I was
delighted to see that XPAND recently announced a clinical solution that
promises to reverse the challenges faced by children and adults with this
unfortunate eye disorder. Called Amblyz,
XPAND has created a medical device used to treat amblyopia, shaped in the form
of normal glasses. Working with world-renowned ophthalmologists and
optometrists, this solution has undergone steep clinical trials as well as
scholarly peer review in scientific journals, and is now launching into the
medical market. Due to the medical nature of this offering, Amblyz is only sold
through referring optometrists and opthalmologists, and not direct to consumers
or patients. You can learn more about this new (and I believe, 3D-influenced)
therapeutic technology at this site: AMBLYZ
No comments:
Post a Comment